Login to Your Account



Evotec, Harvard, J&J Combine in Preclinical Diabetes Alliance

By Cormac Sheridan
Staff Writer

Wednesday, August 8, 2012

CureBeta, the diabetes research alliance between Evotec AG and Doug Melton's lab in Harvard University's Department of Stem Cell and Regenerative Biology, has found an early taker for its preclinical portfolio of small molecules and biologics that can trigger growth of insulin-secreting pancreatic beta cells.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription